Key Points
Oct 27 (Reuters) - The European Medicines Agency (EMA) on Friday said its safety panel did not find a causal link between popular GLP-1 drugs such as Novo Nordisk's (NOVOb.CO).
The panel committee reviewed non-clinical, clinical and post-marketing data of the drugs, and said that no updates to their prescribing information was required at the time...
The agency has since April been monitoring the use of GLP-1 receptor agonists, a class of diabetes and weight loss drugs that includes Ozempic and Wegovy, for any signs that they increase the risk of thyroid cancer...
The safety panel reviewed data from Novo's popular diabetes drug Ozempic and weight loss treatment Wegovy, which contain the same active ingredient, semaglutide...
In July, the regulator also began reviewing a group of GLP-1 drugs after Iceland's health regulator flagged three cases of patients thinking about suicide or self-harm after using Novo's medications...
You might be interested in
Swedish regulator asks doctors not to prescribe diabetes drugs for weight loss
11, Dec, 23Sweden's drugs agency on Monday asked doctors to hold off on prescribing diabetes drugs for the treatment of obesity, pointing to signs that a spike in such usage has left diabetics short of medication.
Has a 'magical' weight loss drug finally arrived? Hopes soar with US firm's never-before-seen results
29, Jun, 23Patients who got a weekly injection of the experimental anti-obesity drug retatrutide lost up to 24 per cent of their body weight in 48 weeks, show phase-2 trials published this week.
Belgium seizes fake weight-loss drugs containing insulin
30, Oct, 23Belgium’s drug regulator said it had seized counterfeit versions of semaglutide, the active ingredient in Novo Nordisk's (NOVOb.CO) popular obesity drug Wegovy, in which the injector pens contained insulin.
Oscars 2023: As Jimmy Kimmel jokes about celebrities popping Ozempic pills for weight loss, know what it is
13, Mar, 23While Ozempic helps in weight loss, it is formally approved only for the treatment of diabetes and should not be consumed as a weight loss medication.
More evidence needed on Lilly's weight loss drug, UK watchdog says
27, Jun, 23UK's drug cost-effectiveness watchdog on Tuesday did not recommend Eli Lilly's weight loss drug for adults with diabetes, saying more evidence was needed before it could be used by the National Health Service (NHS).
Mindy Kaling sparks jokes she's on buzzy drug Ozempic at the Oscars. Here's what she's said about her weight loss.
16, Mar, 23"The Office" actor is among the celebrities people are speculating use Ozempic, a brand name of the weight loss and diabetes drug semaglutide.
German drug regulator considering export ban on Ozempic
15, Nov, 23The head of German drug regulator BfArM is considering an export ban on Novo Nordisk's (NOVOb.CO) diabetes drug Ozempic, which is in high demand for its weight-loss benefits, to prevent a worsened supply shortage.
How well-off Brits still buy Ozempic online for weight loss
18, Nov, 23John, a tech executive who has been battling weight gain since his 30s, has a nine-month supply in his refrigerator. Kim Gradwell, a retired receptionist who developed type 2 diabetes nearly 20 years ago, isn't sure where she'll find her next dose.
Desperate Indians want Ozempic on prescription. Huge shift from traditional drugs, say doctors
15, Oct, 23Given the hype, semaglutide is gaining traction across India with the requests pouring in – more so in private, luxury clinics.